a b
j

Recent Publications

1: Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De
Vivo I, Savage SA. Telomere length and risk of glioma. Cancer Epidemiol. 2013
Dec;37(6):935-8. doi: 10.1016/j.canep.2013.10.002. Epub 2013 Nov 11. PubMed PMID:
24231251.

2: Du M, Kraft P, Heather Eliassen A, Giovannucci E, Hankinson SE, De Vivo I.
Physical activity and risk of endometrial adenocarcinoma in the Nurses' Health
Study. Int J Cancer. 2013 Nov 10. doi: 10.1002/ijc.28599. [Epub ahead of print]
PubMed PMID: 24213924.

3: Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson
L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S,
Dinney CP, Malats N, Baris D, Purdue M, Jacobs EJ, Albanes D, Wang Z, Deng X,
Chung CC, Tang W, Bas Bueno-de-Mesquita H, Trichopoulos D, Ljungberg B,
Clavel-Chapelon F, Weiderpass E, Krogh V, Dorronsoro M, Travis R, Tjønneland A,
Brenan P, Chang-Claude J, Riboli E, Conti D, Gago-Dominguez M, Stern MC, Pike MC,
Van Den Berg D, Yuan JM, Hohensee C, Rodabough R, Cancel-Tassin G, Roupret M,
Comperat E, Chen C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, Lindstrom S,
Carta A, Pavanello S, Arici C, Mastrangelo G, Kamat AM, Lerner SP, Barton
Grossman H, Lin J, Gu J, Pu X, Hutchinson A, Burdette L, Wheeler W, Kogevinas M,
Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Schwenn M, Karagas MR,
Johnson A, Schned A, Armenti KR, Hosain GM, Andriole G Jr, Grubb R 3rd, Black A,
Ryan Diver W, Gapstur SM, Weinstein SJ, Virtamo J, Haiman CA, Landi MT, Caporaso
N, Fraumeni JF Jr, Vineis P, Wu X, Silverman DT, Chanock S, Rothman N.
Genome-wide association study identifies multiple loci associated with bladder
cancer risk. Hum Mol Genet. 2013 Nov 23. [Epub ahead of print] PubMed PMID:
24163127.

4: De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N; Australian
National Endometrial Cancer Study Group, Attia J, Black A, Brinton L, Chen C,
Chen C, Cook LS, Crous-Bou M, Doherty J, Dunning AM, Easton DF, Friedenreich CM,
Garcia-Closas M, Gaudet MM, Haiman C, Hankinson SE, Hartge P, Henderson BE,
Holliday E, Horn-Ross PL, Hunter DJ, Le Marchand L, Liang X, Lissowska J, Long J,
Lu L, Magliocco AM, McEvoy M, O'Mara TA, Orlow I, Painter JN, Pooler L, Rastogi
R, Rebbeck TR, Risch H, Sacerdote C, Schumacher F, Scott RJ, Sheng X, Shu XO,
Spurdle AB, Thompson D, Vanden Berg D, Weiss NS, Xia L, Xiang YB, Yang HP, Yu H,
Zheng W, Chanock S, Kraft P. Genome-wide association study of endometrial cancer
in E2C2. Hum Genet. 2014 Feb;133(2):211-24. doi: 10.1007/s00439-013-1369-1. Epub
2013 Oct 6. PubMed PMID: 24096698.

5: Guffanti G, Galea S, Yan L, Roberts AL, Solovieff N, Aiello AE, Smoller JW, De
Vivo I, Ranu H, Uddin M, Wildman DE, Purcell S, Koenen KC. Genome-wide
association study implicates a novel RNA gene, the lincRNA AC068718.1, as a risk
factor for post-traumatic stress disorder in women. Psychoneuroendocrinology.
2013 Dec;38(12):3029-38. doi: 10.1016/j.psyneuen.2013.08.014. Epub 2013 Sep 8.
PubMed PMID: 24080187; PubMed Central PMCID: PMC3844079.

6: Burke LS, Hyland PL, Pfeiffer RM, Prescott J, Wheeler W, Mirabello L, Savage
SA, Burdette L, Yeager M, Chanock S, De Vivo I, Tucker MA, Goldstein AM, Yang XR.
Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone
families with and without CDKN2A mutations. PLoS One. 2013 Aug 19;8(8):e71121.
doi: 10.1371/journal.pone.0071121. PubMed PMID: 23990928; PubMed Central PMCID:
PMC3747185.

7: Kang JH, Kueck AS, Stevens R, Curhan G, De Vivo I, Rosner B, Alexander E,
Tworoger SS. A large cohort study of hypothyroidism and hyperthyroidism in
relation to gynecologic cancers. Obstet Gynecol Int. 2013;2013:743721. doi:
10.1155/2013/743721. Epub 2013 Jul 15. PubMed PMID: 23956749; PubMed Central
PMCID: PMC3728510.

8: Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen
N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ; Australian
National Endometrial Cancer Study Group, Strom BL, Spurdle AB, Soslow RA, Shu XO,
Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR,
Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB,
McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X,
Lacey JV Jr, Kolonel LN, Henderson BE, Hankinson SE, Håkansson N, Goodman MT,
Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo
I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L,
Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL. Type I and II endometrial
cancers: have they different risk factors? J Clin Oncol. 2013 Jul
10;31(20):2607-18. doi: 10.1200/JCO.2012.48.2596. Epub 2013 Jun 3. Review. PubMed
PMID: 23733771; PubMed Central PMCID: PMC3699726.

9: Liu JJ, Prescott J, Giovannucci E, Hankinson SE, Rosner B, Han J, De Vivo I.
Plasma vitamin D biomarkers and leukocyte telomere length. Am J Epidemiol. 2013
Jun 15;177(12):1411-7. doi: 10.1093/aje/kws435. Epub 2013 May 9. PubMed PMID:
23660800; PubMed Central PMCID: PMC3676154.

10: Hoge EA, Chen MM, Orr E, Metcalf CA, Fischer LE, Pollack MH, De Vivo I, Simon
NM. Loving-Kindness Meditation practice associated with longer telomeres in
women. Brain Behav Immun. 2013 Aug;32:159-63. doi: 10.1016/j.bbi.2013.04.005.
Epub 2013 Apr 19. PubMed PMID: 23602876.

11: Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D,
Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas
M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J,
Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A,
Gapstur SM, Thun M, Diver WR, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N,
Landi MT, Hutchinson A, Burdett L, Jacobs KB, Yeager M, Fraumeni JF Jr, Chanock
SJ, Silverman DT, Chatterjee N. Common genetic polymorphisms modify the effect of
smoking on absolute risk of bladder cancer. Cancer Res. 2013 Apr 1;73(7):2211-20.
doi: 10.1158/0008-5472.CAN-12-2388. Epub 2013 Mar 27. PubMed PMID: 23536561;
PubMed Central PMCID: PMC3688270.

12: Schürks M, Prescott J, Dushkes R, De Vivo I, Rexrode KM. Telomere length and
ischaemic stroke in women: a nested case-control study. Eur J Neurol. 2013
Jul;20(7):1068-74. doi: 10.1111/ene.12135. Epub 2013 Mar 21. PubMed PMID:
23521613; PubMed Central PMCID: PMC3681869.

13: Liu JJ, Prescott J, Giovannucci E, Hankinson SE, Rosner B, De Vivo I.
One-carbon metabolism factors and leukocyte telomere length. Am J Clin Nutr. 2013
Apr;97(4):794-9. doi: 10.3945/ajcn.112.051557. Epub 2013 Feb 27. PubMed PMID:
23446900; PubMed Central PMCID: PMC3607653.

14: Du M, Prescott J, Cornelis MC, Hankinson SE, Giovannucci E, Kraft P, De Vivo
I. Genetic predisposition to higher body mass index or type 2 diabetes and
leukocyte telomere length in the Nurses' Health Study. PLoS One.
2013;8(2):e52240. doi: 10.1371/journal.pone.0052240. Epub 2013 Feb 12. PubMed
PMID: 23424613; PubMed Central PMCID: PMC3570546.

15: Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA,
Anderson KE, Bernstein L, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA,
Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco
A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, Patel AV, Prescott J,
Rastogi R, Robien K, Rosenberg L, Schairer C, Ou Shu X, van den Brandt PA, Virkus
RA, Wentzensen N, Xiang YB, Xu WH, Yang HP, Brinton LA. The etiology of uterine
sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.
Br J Cancer. 2013 Feb 19;108(3):727-34. doi: 10.1038/bjc.2013.2. Epub 2013 Jan
24. PubMed PMID: 23348519; PubMed Central PMCID: PMC3593566.

16: Liu JJ, Hazra A, Giovannucci E, Hankinson SE, Rosner B, De Vivo I. One-carbon
metabolism factors and endometrial cancer risk. Br J Cancer. 2013 Jan
15;108(1):183-7. doi: 10.1038/bjc.2012.534. Epub 2013 Jan 8. PubMed PMID:
23299529; PubMed Central PMCID: PMC3553527.

17: Liu JJ, Bertrand KA, Karageorgi S, Giovannucci E, Hankinson SE, Rosner B,
Maxwell L, Rodriguez G, De Vivo I. Prospective analysis of vitamin D and
endometrial cancer risk. Ann Oncol. 2013 Mar;24(3):687-92. doi:
10.1093/annonc/mds509. Epub 2012 Nov 7. PubMed PMID: 23136228; PubMed Central
PMCID: PMC3574547.

18: Prescott J, Du M, Wong JY, Han J, De Vivo I. Paternal age at birth is
associated with offspring leukocyte telomere length in the nurses' health study.
Hum Reprod. 2012 Dec;27(12):3622-31. doi: 10.1093/humrep/des314. Epub 2012 Aug
30. PubMed PMID: 22940768; PubMed Central PMCID: PMC3501241.

19: Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L,
Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman
MT, Hankinson SE, Lacey JV Jr, Liang X, Lissowska J, Lu L, Lurie G, Mack T,
Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H,
Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb
PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De Vivo I;
Australian National Endometrial Cancer Study Group. Age at last birth in relation
to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial
cancer consortium. Am J Epidemiol. 2012 Aug 15;176(4):269-78. Epub 2012 Jul 23.
PubMed PMID: 22831825; PubMed Central PMCID: PMC3491967.

20: Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimäki T, Keildson S, Lunetta
KL, He C, Fornage M, Lagou V, Mangino M, Onland-Moret NC, Chen B, Eriksson J,
Garcia M, Liu YM, Koster A, Lohman K, Lyytikäinen LP, Petersen AK, Prescott J,
Stolk L, Vandenput L, Wood AR, Zhuang WV, Ruokonen A, Hartikainen AL, Pouta A,
Bandinelli S, Biffar R, Brabant G, Cox DG, Chen Y, Cummings S, Ferrucci L, Gunter
MJ, Hankinson SE, Martikainen H, Hofman A, Homuth G, Illig T, Jansson JO, Johnson
AD, Karasik D, Karlsson M, Kettunen J, Kiel DP, Kraft P, Liu J, Ljunggren Ö,
Lorentzon M, Maggio M, Markus MR, Mellström D, Miljkovic I, Mirel D, Nelson S,
Morin Papunen L, Peeters PH, Prokopenko I, Raffel L, Reincke M, Reiner AP,
Rexrode K, Rivadeneira F, Schwartz SM, Siscovick D, Soranzo N, Stöckl D, Tworoger
S, Uitterlinden AG, van Gils CH, Vasan RS, Wichmann HE, Zhai G, Bhasin S,
Bidlingmaier M, Chanock SJ, De Vivo I, Harris TB, Hunter DJ, Kähönen M, Liu S,
Ouyang P, Spector TD, van der Schouw YT, Viikari J, Wallaschofski H, McCarthy MI,
Frayling TM, Murray A, Franks S, Järvelin MR, de Jong FH, Raitakari O, Teumer A,
Ohlsson C, Murabito JM, Perry JR. A genome-wide association meta-analysis of
circulating sex hormone-binding globulin reveals multiple Loci implicated in sex
steroid hormone regulation. PLoS Genet. 2012;8(7):e1002805. doi:
10.1371/journal.pgen.1002805. Epub 2012 Jul 19. PubMed PMID: 22829776; PubMed
Central PMCID: PMC3400553.

21: Okereke OI, Prescott J, Wong JY, Han J, Rexrode KM, De Vivo I. High phobic
anxiety is related to lower leukocyte telomere length in women. PLoS One.
2012;7(7):e40516. doi: 10.1371/journal.pone.0040516. Epub 2012 Jul 11. PubMed
PMID: 22808180; PubMed Central PMCID: PMC3394740.

22: Prescott J, Thompson DJ, Kraft P, Chanock SJ, Audley T, Brown J, Leyland J,
Folkerd E, Doody D, Hankinson SE, Hunter DJ, Jacobs KB, Dowsett M, Cox DG, Easton
DF, De Vivo I. Genome-wide association study of circulating estradiol,
testosterone, and sex hormone-binding globulin in postmenopausal women. PLoS One.
2012;7(6):e37815. doi: 10.1371/journal.pone.0037815. Epub 2012 Jun 4. PubMed
PMID: 22675492; PubMed Central PMCID: PMC3366971.

23: Sun Q, Shi L, Prescott J, Chiuve SE, Hu FB, De Vivo I, Stampfer MJ, Franks
PW, Manson JE, Rexrode KM. Healthy lifestyle and leukocyte telomere length in
U.S. women. PLoS One. 2012;7(5):e38374. doi: 10.1371/journal.pone.0038374. Epub
2012 May 31. PubMed PMID: 22675460; PubMed Central PMCID: PMC3365002.

24: Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De
Vivo I, Nitti D. Telomerase reverse transcriptase locus polymorphisms and cancer
risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012 Jun
6;104(11):840-54. doi: 10.1093/jnci/djs222. Epub 2012 Apr 20. Review. PubMed
PMID: 22523397; PubMed Central PMCID: PMC3611810.

25: Du M, Prescott J, Kraft P, Han J, Giovannucci E, Hankinson SE, De Vivo I.
Physical activity, sedentary behavior, and leukocyte telomere length in women. Am
J Epidemiol. 2012 Mar 1;175(5):414-22. doi: 10.1093/aje/kwr330. Epub 2012 Feb 1.
PubMed PMID: 22302075; PubMed Central PMCID: PMC3282876.

26: Terry KL, Tworoger SS, Vitonis AF, Wong J, Titus-Ernstoff L, De Vivo I,
Cramer DW. Telomere length and genetic variation in telomere maintenance genes in
relation to ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2012
Mar;21(3):504-12. doi: 10.1158/1055-9965.EPI-11-0867. Epub 2012 Jan 20. PubMed
PMID: 22267287; PubMed Central PMCID: PMC3297716.

27: Tang W, Fu YP, Figueroa JD, Malats N, Garcia-Closas M, Chatterjee N,
Kogevinas M, Baris D, Thun M, Hall JL, De Vivo I, Albanes D, Porter-Gill P,
Purdue MP, Burdett L, Liu L, Hutchinson A, Myers T, Tardón A, Serra C, Carrato A,
Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Black A,
Jacobs EJ, Diver WR, Gapstur SM, Virtamo J, Hunter DJ, Fraumeni JF Jr, Chanock
SJ, Silverman DT, Rothman N, Prokunina-Olsson L. Mapping of the UGT1A locus
identifies an uncommon coding variant that affects mRNA expression and protects
from bladder cancer. Hum Mol Genet. 2012 Apr 15;21(8):1918-30. doi:
10.1093/hmg/ddr619. Epub 2012 Jan 6. PubMed PMID: 22228101; PubMed Central PMCID:
PMC3313801.

28: Je Y, Hankinson SE, Tworoger SS, De Vivo I, Giovannucci E. A prospective
cohort study of coffee consumption and risk of endometrial cancer over a 26-year
follow-up. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2487-95. doi:
10.1158/1055-9965.EPI-11-0766. Epub 2011 Nov 22. PubMed PMID: 22109346; PubMed
Central PMCID: PMC3237942.

29: Nan H, Du M, De Vivo I, Manson JE, Liu S, McTiernan A, Curb JD, Lessin LS,
Bonner MR, Guo Q, Qureshi AA, Hunter DJ, Han J. Shorter telomeres associate with
a reduced risk of melanoma development. Cancer Res. 2011 Nov 1;71(21):6758-63.
doi: 10.1158/0008-5472.CAN-11-1988. Epub 2011 Oct 25. PubMed PMID: 22028319;
PubMed Central PMCID: PMC3206204.

30: Chang SC, Xie P, Anton RF, De Vivo I, Farrer LA, Kranzler HR, Oslin D,
Purcell SM, Roberts AL, Smoller JW, Uddin M, Gelernter J, Koenen KC. No
association between ADCYAP1R1 and post-traumatic stress disorder in two
independent samples. Mol Psychiatry. 2012 Mar;17(3):239-41. doi:
10.1038/mp.2011.118. Epub 2011 Sep 13. PubMed PMID: 21912390.

31: Liang G, Schernhammer E, Qi L, Gao X, De Vivo I, Han J. Associations between
rotating night shifts, sleep duration, and telomere length in women. PLoS One.
2011;6(8):e23462. doi: 10.1371/journal.pone.0023462. Epub 2011 Aug 10. PubMed
PMID: 21853136; PubMed Central PMCID: PMC3154494.

32: Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP,
Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D,
Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP,
Grossman HB, Gu J, Pu X, Hutchinson A, Fu YP, Burdett L, Yeager M, Tang W, Tardón
A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas
MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur
SM, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Fraumeni JF Jr,
Silverman DT, Chanock SJ, Wu X. A genome-wide association study of bladder cancer
identifies a new susceptibility locus within SLC14A1, a urea transporter gene on
chromosome 18q12.3. Hum Mol Genet. 2011 Nov 1;20(21):4282-9. doi:
10.1093/hmg/ddr342. Epub 2011 Aug 8. PubMed PMID: 21824976; PubMed Central PMCID:
PMC3188994.

33: Prescott J, Wentzensen IM, Savage SA, De Vivo I. Epidemiologic evidence for a
role of telomere dysfunction in cancer etiology. Mutat Res. 2012 Feb
1;730(1-2):75-84. doi: 10.1016/j.mrfmmm.2011.06.009. Epub 2011 Jul 2. Review.
PubMed PMID: 21756922; PubMed Central PMCID: PMC3222719.

34: Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Carney ME,
Palmieri RT, Wu AH, Pike MC, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA,
Ramus SJ, Whittemore AS, McGuire V, Sieh W, Pharoah PD, Song H, Gronwald J,
Jakubowska A, Cybulski C, Lubinski J, Schildkraut JM, Berchuck A, Krüger Kjær S,
Høgdall E, Fasching PA, Beckmann MW, Ekici AB, Hein A, Chenevix-Trench G, Webb
PM, Beesley J; Australian Ovarian Cancer Study Group; Australian Cancer Study
Group, Goodman MT; Ovarian Cancer Association Consortium. Estrogen receptor beta
rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis
within the Ovarian Cancer Association Consortium. PLoS One. 2011;6(6):e20703.
doi: 10.1371/journal.pone.0020703. Epub 2011 Jun 6. PubMed PMID: 21673961; PubMed
Central PMCID: PMC3108970.

35: Ter-Minassian M, Wang Z, Asomaning K, Wu MC, Liu CY, Paulus JK, Liu G,
Bradbury PA, Zhai R, Su L, Frauenhoffer CS, Hooshmand SM, De Vivo I, Lin X,
Christiani DC, Kulke MH. Genetic associations with sporadic neuroendocrine tumor
risk. Carcinogenesis. 2011 Aug;32(8):1216-22. doi: 10.1093/carcin/bgr095. Epub
2011 May 23. PubMed PMID: 21606320; PubMed Central PMCID: PMC3149206.

36: Drury SS, Theall K, Gleason MM, Smyke AT, De Vivo I, Wong JY, Fox NA, Zeanah
CH, Nelson CA. Telomere length and early severe social deprivation: linking early
adversity and cellular aging. Mol Psychiatry. 2012 Jul;17(7):719-27. doi:
10.1038/mp.2011.53. Epub 2011 May 17. PubMed PMID: 21577215; PubMed Central
PMCID: PMC3518061.

37: Costenbader KH, Prescott J, Zee RY, De Vivo I. Immunosenescence and
rheumatoid arthritis: does telomere shortening predict impending disease?
Autoimmun Rev. 2011 Jul;10(9):569-73. doi: 10.1016/j.autrev.2011.04.034. Epub
2011 May 7. Review. PubMed PMID: 21575746; PubMed Central PMCID: PMC3119949.

38: Prescott J, Kraft P, Chasman DI, Savage SA, Mirabello L, Berndt SI, Weissfeld
JL, Han J, Hayes RB, Chanock SJ, Hunter DJ, De Vivo I. Genome-wide association
study of relative telomere length. PLoS One. 2011 May 10;6(5):e19635. doi:
10.1371/journal.pone.0019635. PubMed PMID: 21573004; PubMed Central PMCID:
PMC3091863.

39: Liang G, Qureshi AA, Guo Q, De Vivo I, Han J. No association between telomere
length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer.
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1043-5. doi:
10.1158/1055-9965.EPI-11-0072. Epub 2011 Feb 25. PubMed PMID: 21357377; PubMed
Central PMCID: PMC3089713.

40: Karageorgi S, Prescott J, Wong JY, Lee IM, Buring JE, De Vivo I. GSTM1 and
GSTT1 copy number variation in population-based studies of endometrial cancer
risk. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1447-52. doi:
10.1158/1055-9965.EPI-11-0190. Epub 2011 May 10. PubMed PMID: 21558497; PubMed
Central PMCID: PMC3157698.

41: Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS,
Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I,
O'Mara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, Le
Marchand L, Kolonel LN, Henderson BE, Garcia-Closas M, Doherty JA, De Vivo I,
Chen C, Brinton LA, Akbari MR; Australian National Endometrial Cancer Study
Group; Epidemiology of Endometrial Cancer Consortium (E2C2), Goodman MT. The
obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and
endometrial cancer risk in non-Hispanic white women. PLoS One. 2011 Feb
8;6(2):e16756. doi: 10.1371/journal.pone.0016756. PubMed PMID: 21347432; PubMed
Central PMCID: PMC3035652.

42: Devore EE, Prescott J, De Vivo I, Grodstein F. Relative telomere length and
cognitive decline in the Nurses' Health Study. Neurosci Lett. 2011 Mar
29;492(1):15-8. doi: 10.1016/j.neulet.2011.01.041. Epub 2011 Feb 2. PubMed PMID:
21295115; PubMed Central PMCID: PMC3306217.

43: Karageorgi S, McGrath M, Lee IM, Buring J, Kraft P, De Vivo I. Polymorphisms
in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial
cancer risk. Gynecol Oncol. 2011 Apr;121(1):54-8. doi:
10.1016/j.ygyno.2010.11.014. Epub 2010 Dec 3. PubMed PMID: 21129770; PubMed
Central PMCID: PMC3062639.

44: Nan H, Qureshi AA, Prescott J, De Vivo I, Han J. Genetic variants in
telomere-maintaining genes and skin cancer risk. Hum Genet. 2011
Mar;129(3):247-53. doi: 10.1007/s00439-010-0921-5. Epub 2010 Nov 30. PubMed PMID:
21116649; PubMed Central PMCID: PMC3443196.

45: McGrath M, Lee IM, Buring J, De Vivo I. Common genetic variation within IGFI,
IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk. Gynecol Oncol. 2011
Feb;120(2):174-8. doi: 10.1016/j.ygyno.2010.10.012. PubMed PMID: 21078522; PubMed
Central PMCID: PMC3238452.

46: Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real
FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I,
Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K,
Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z,
Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardón A, Serra C,
Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned
A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur SM,
Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan
JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH,
Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E,
Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D,
Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F,
Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C,
Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T,
Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D
García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni
JF Jr, Silverman DT, Chanock SJ. A multi-stage genome-wide association study of
bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010
Nov;42(11):978-84. doi: 10.1038/ng.687. Epub 2010 Oct 24. PubMed PMID: 20972438;
PubMed Central PMCID: PMC3049891.

47: Terry KL, De Vivo I, Hankinson SE, Missmer SA. Reproductive characteristics
and risk of uterine leiomyomata. Fertil Steril. 2010 Dec;94(7):2703-7. doi:
10.1016/j.fertnstert.2010.04.065. Epub 2010 Jun 8. PubMed PMID: 20627243; PubMed
Central PMCID: PMC2956020.

48: Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, Wong JY,
Chatterjee N, Hayes RB, Savage SA. The association of telomere length and genetic
variation in telomere biology genes. Hum Mutat. 2010 Sep;31(9):1050-8. doi:
10.1002/humu.21314. PubMed PMID: 20597107; PubMed Central PMCID: PMC2932868.

49: Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, Helzlsouer KJ, McCullough
ML, Setiawan VW, Shu XO, Weinstein SJ, Weiss JM, Arslan AA, De Vivo I, Gao YT,
Hayes RB, Henderson BE, Horst RL, Koenig KL, Patel AV, Purdue MP, Snyder K,
Steplowski E, Yu K, Zheng W, Hankinson SE. Circulating 25-hydroxyvitamin D and
risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer
Cancers. Am J Epidemiol. 2010 Jul 1;172(1):36-46. doi: 10.1093/aje/kwq114. Epub
2010 Jun 18. PubMed PMID: 20562189; PubMed Central PMCID: PMC2892537.

50: Prescott J, McGrath M, Lee IM, Buring JE, De Vivo I. Telomere length and
genetic analyses in population-based studies of endometrial cancer risk. Cancer.
2010 Sep 15;116(18):4275-82. doi: 10.1002/cncr.25328. PubMed PMID: 20549820;
PubMed Central PMCID: PMC2978514.

51: Karageorgi S, Gates MA, Hankinson SE, De Vivo I. Perineal use of talcum
powder and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2010
May;19(5):1269-75. doi: 10.1158/1055-9965.EPI-09-1221. Epub 2010 Apr 20. PubMed
PMID: 20406962; PubMed Central PMCID: PMC2866017.

52: Cassidy A, De Vivo I, Liu Y, Han J, Prescott J, Hunter DJ, Rimm EB.
Associations between diet, lifestyle factors, and telomere length in women. Am J
Clin Nutr. 2010 May;91(5):1273-80. doi: 10.3945/ajcn.2009.28947. Epub 2010 Mar
10. PubMed PMID: 20219960; PubMed Central PMCID: PMC2854902.

53: Terry K, McGrath M, Lee IM, Buring J, De Vivo I. Genetic variation in CYP11A1
and StAR in relation to endometrial cancer risk. Gynecol Oncol. 2010
May;117(2):255-9. doi: 10.1016/j.ygyno.2010.02.002. Epub 2010 Mar 2. PubMed PMID:
20199803; PubMed Central PMCID: PMC2849850.

54: Pinheiro SP, Gates MA, De Vivo I, Rosner BA, Tworoger SS, Titus-Ernstoff L,
Hankinson SE, Cramer DW. Interaction between use of non-steroidal
anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer
risk. Int J Mol Epidemiol Genet. 2010 Sep 3;1(4):320-31. PubMed PMID: 21532843;
PubMed Central PMCID: PMC3076777.

55: Ogino S, Nosho K, Shima K, Baba Y, Irahara N, Kirkner GJ, Hazra A, De Vivo I,
Giovannucci EL, Meyerhardt JA, Fuchs CS. p21 expression in colon cancer and
modifying effects of patient age and body mass index on prognosis. Cancer
Epidemiol Biomarkers Prev. 2009 Sep;18(9):2513-21. doi:
10.1158/1055-9965.EPI-09-0451. Epub 2009 Sep 1. PubMed PMID: 19723919; PubMed
Central PMCID: PMC2758547.

56: Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E,
Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman
MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J,
Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, Dürst M, Ekici
AB, Fenstermacher D, Fridley BL, Giles G, Gore ME, De Vivo I, Hillemanns P,
Hogdall C, Hogdall E, Iversen ES, Jacobs IJ, Jakubowska A, Li D, Lissowska J,
Lubiński J, Lurie G, McGuire V, McLaughlin J, Medrek K, Moorman PG, Moysich K,
Narod S, Phelan C, Pye C, Risch H, Runnebaum IB, Severi G, Southey M, Stram DO,
Thiel FC, Terry KL, Tsai YY, Tworoger SS, Van Den Berg DJ, Vierkant RA,
Wang-Gohrke S, Webb PM, Wilkens LR, Wu AH, Yang H, Brewster W, Ziogas A;
Australian Cancer (Ovarian) Study; Australian Ovarian Cancer Study Group; Ovarian
Cancer Association Consortium, Houlston R, Tomlinson I, Whittemore AS, Rossing
MA, Ponder BA, Pearce CL, Ness RB, Menon U, Kjaer SK, Gronwald J, Garcia-Closas
M, Fasching PA, Easton DF, Chenevix-Trench G, Berchuck A, Pharoah PD, Gayther SA.
A genome-wide association study identifies a new ovarian cancer susceptibility
locus on 9p22.2. Nat Genet. 2009 Sep;41(9):996-1000. doi: 10.1038/ng.424. Epub
2009 Aug 2. PubMed PMID: 19648919; PubMed Central PMCID: PMC2844110.

57: Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH,
Fraser PA, Tworoger S, Hankinson SE, Lee IM, Buring J, De Vivo I. A prospective
study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.
Arthritis Res Ther. 2009;11(3):R97. doi: 10.1186/ar2742. Epub 2009 Jun 25. PubMed
PMID: 19555469; PubMed Central PMCID: PMC2714153.

58: Karageorgi S, Hankinson SE, Kraft P, De Vivo I. Reproductive factors and
postmenopausal hormone use in relation to endometrial cancer risk in the Nurses'
Health Study cohort 1976-2004. Int J Cancer. 2010 Jan 1;126(1):208-16. doi:
10.1002/ijc.24672. PubMed PMID: 19551854; PubMed Central PMCID: PMC2784268.

59: Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De Vivo
I, Hayes RB, Savage SA. The association between leukocyte telomere length and
cigarette smoking, dietary and physical variables, and risk of prostate cancer.
Aging Cell. 2009 Aug;8(4):405-13. doi: 10.1111/j.1474-9726.2009.00485.x. Epub
2009 Jun 1. PubMed PMID: 19493248; PubMed Central PMCID: PMC2742954.

60: Koenen KC, De Vivo I, Rich-Edwards J, Smoller JW, Wright RJ, Purcell SM.
Protocol for investigating genetic determinants of posttraumatic stress disorder
in women from the Nurses' Health Study II. BMC Psychiatry. 2009 May 29;9:29. doi:
10.1186/1471-244X-9-29. PubMed PMID: 19480706; PubMed Central PMCID: PMC2698903.

61: Kotsopoulos J, Tworoger SS, De Vivo I, Hankinson SE, Hunter DJ, Willett WC,
Chen WY. +331G/A variant in the progesterone receptor gene, postmenopausal
hormone use and risk of breast cancer. Int J Cancer. 2009 Oct 1;125(7):1685-91.
doi: 10.1002/ijc.24477. Erratum in: Int J Cancer. 2009 Nov 15;125(10):2487.
DeVivo, Immaculata [corrected to De Vivo, Immaculata]. PubMed PMID: 19462450;
PubMed Central PMCID: PMC2736114.

62: Lee YC, Raychaudhuri S, Cui J, De Vivo I, Ding B, Alfredsson L, Padyukov L,
Costenbader KH, Seielstad M, Graham RR, Klareskog L, Gregersen PK, Plenge RM,
Karlson EW. The PRL -1149 G/T polymorphism and rheumatoid arthritis
susceptibility. Arthritis Rheum. 2009 May;60(5):1250-4. doi: 10.1002/art.24468.
PubMed PMID: 19404952; PubMed Central PMCID: PMC2956274.

63: McGrath M, Lepine J, Lee IM, Villeneuve L, Buring J, Guillemette C, De Vivo
I. Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.
Pharmacogenet Genomics. 2009 Mar;19(3):239-43. doi: 10.1097/FPC.0b013e328323f66c.
PubMed PMID: 19352303; PubMed Central PMCID: PMC2667627.

64: Hartong DT, McGee TL, Sandberg MA, Berson EL, Asselbergs FW, van der Harst P,
De Vivo I, Dryja TP. Search for a correlation between telomere length and
severity of retinitis pigmentosa due to the dominant rhodopsin Pro23His mutation.
Mol Vis. 2009;15:592-7. Epub 2009 Mar 27. PubMed PMID: 19325938; PubMed Central
PMCID: PMC2661004.

65: De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, Hunter DJ. A
prospective study of relative telomere length and postmenopausal breast cancer
risk. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1152-6. doi:
10.1158/1055-9965.EPI-08-0998. Epub 2009 Mar 17. PubMed PMID: 19293310; PubMed
Central PMCID: PMC2732000.

66: Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, De Vivo I, Costenbader
KH. Gene-environment interaction between HLA-DRB1 shared epitope and heavy
cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis.
2010 Jan;69(1):54-60. doi: 10.1136/ard.2008.102962. Epub . PubMed PMID: 19151010;
PubMed Central PMCID: PMC2952498.

67: Olson SH, Chen C, De Vivo I, Doherty JA, Hartmuller V, Horn-Ross PL, Lacey JV
Jr, Lynch SM, Sansbury L, Setiawan VW, Schouten LJ, Shu XO. Maximizing resources
to study an uncommon cancer: E2C2--Epidemiology of Endometrial Cancer Consortium.
Cancer Causes Control. 2009 May;20(4):491-6. doi: 10.1007/s10552-008-9290-y. Epub
2009 Jan 9. PubMed PMID: 19132539; PubMed Central PMCID: PMC2868317.

68: Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, Demichele A,
Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL,
Lacey JV Jr, Le Marchand L, Levine DA, Liang X, Lissowska J, Lurie G, McGrath M,
Narod SA, Rebbeck TR, Ursin G, Weiss NS, Xiang YB, Yang HP, Zheng W, Olson SH.
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled
analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol
Biomarkers Prev. 2009 Jan;18(1):242-7. doi: 10.1158/1055-9965.EPI-08-0689. PubMed
PMID: 19124504; PubMed Central PMCID: PMC2668570.

69: Gates MA, Tworoger SS, Terry KL, De Vivo I, Hunter DJ, Hankinson SE, Cramer
DW. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study
populations. Int J Cancer. 2009 Feb 1;124(3):729-33. doi: 10.1002/ijc.23924.
PubMed PMID: 18973230; PubMed Central PMCID: PMC2679694.

70: Kotsopoulos J, Vitonis AF, Terry KL, De Vivo I, Cramer DW, Hankinson SE,
Tworoger SS. Coffee intake, variants in genes involved in caffeine metabolism,
and the risk of epithelial ovarian cancer. Cancer Causes Control. 2009
Apr;20(3):335-44. doi: 10.1007/s10552-008-9247-1. Epub 2008 Oct 21. PubMed PMID:
18941913; PubMed Central PMCID: PMC2692932.

71: Grodstein F, van Oijen M, Irizarry MC, Rosas HD, Hyman BT, Growdon JH, De
Vivo I. Shorter telomeres may mark early risk of dementia: preliminary analysis
of 62 participants from the nurses' health study. PLoS One. 2008 Feb
13;3(2):e1590. doi: 10.1371/journal.pone.0001590. PubMed PMID: 18795148; PubMed
Central PMCID: PMC2536511.

72: McGrath M, Lee IM, Buring J, Hunter DJ, De Vivo I. Novel breast cancer risk
alleles and endometrial cancer risk. Int J Cancer. 2008 Dec 15;123(12):2961-4.
doi: 10.1002/ijc.23862. PubMed PMID: 18785201; PubMed Central PMCID: PMC2605169.

73: Gates MA, Tworoger SS, Terry KL, Titus-Ernstoff L, Rosner B, De Vivo I,
Cramer DW, Hankinson SE. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes,
and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2008
Sep;17(9):2436-44. doi: 10.1158/1055-9965.EPI-08-0399. PubMed PMID: 18768514;
PubMed Central PMCID: PMC2630413.

74: Ter-Minassian M, Zhai R, Asomaning K, Su L, Zhou W, Liu G, Heist RS, Lynch
TJ, Wain JC, Lin X, De Vivo I, Christiani DC. Apoptosis gene polymorphisms, age,
smoking and the risk of non-small cell lung cancer. Carcinogenesis. 2008
Nov;29(11):2147-52. doi: 10.1093/carcin/bgn205. Epub 2008 Aug 29. PubMed PMID:
18757527; PubMed Central PMCID: PMC2577138.

75: Shammas MA, Qazi A, Batchu RB, Bertheau RC, Wong JY, Rao MY, Prasad M, Chanda
D, Ponnazhagan S, Anderson KC, Steffes CP, Munshi NC, De Vivo I, Beer DG,
Gryaznov S, Weaver DW, Goyal RK. Telomere maintenance in laser capture
microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase
inhibition in vivo. Clin Cancer Res. 2008 Aug 1;14(15):4971-80. doi:
10.1158/1078-0432.CCR-08-0473. PubMed PMID: 18676772; PubMed Central PMCID:
PMC2705940.

76: Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ, De Vivo I. A
prospective study of telomere length and the risk of skin cancer. J Invest
Dermatol. 2009 Feb;129(2):415-21. doi: 10.1038/jid.2008.238. Epub 2008 Jul 31.
PubMed PMID: 18668136; PubMed Central PMCID: PMC2632304.

77: Costenbader KH, Chang SC, De Vivo I, Plenge R, Karlson EW. Genetic
polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in
two longitudinal cohort studies: evidence of gene-environment interactions with
heavy cigarette smoking. Arthritis Res Ther. 2008;10(3):R52. doi: 10.1186/ar2421.
Epub 2008 May 7. PubMed PMID: 18462498; PubMed Central PMCID: PMC2483441.

78: Wong JY, Huggins GS, Debidda M, Munshi NC, De Vivo I. Dichloroacetate induces
apoptosis in endometrial cancer cells. Gynecol Oncol. 2008 Jun;109(3):394-402.
doi: 10.1016/j.ygyno.2008.01.038. Epub 2008 Apr 18. PubMed PMID: 18423823; PubMed
Central PMCID: PMC2735772.

79: Terry K, McGrath M, Lee IM, Buring J, De Vivo I. MDM2 SNP309 is associated
with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2008
Apr;17(4):983-6. doi: 10.1158/1055-9965.EPI-07-2872. PubMed PMID: 18398041;
PubMed Central PMCID: PMC2728574.

80: Crous-Bou M, De Vivo I, Porta M, Pumarega JA, López T, Alguacil J, Morales E,
Malats N, Rifà J, Hunter DJ, Real FX; PANKRAS II Study Group. CYP1B1
polymorphisms and k-ras mutations in patients with pancreatic ductal
adenocarcinoma. Dig Dis Sci. 2008 May;53(5):1417-21. doi:
10.1007/s10620-008-0235-9. Epub 2008 Mar 18. PubMed PMID: 18347981.

81: Wang H, Chen H, Gao X, McGrath M, Deer D, De Vivo I, Schwarzschild MA,
Ascherio A. Telomere length and risk of Parkinson's disease. Mov Disord. 2008 Jan
30;23(2):302-5. PubMed PMID: 18044760; PubMed Central PMCID: PMC2387100.

82: Terry KL, Missmer SA, Hankinson SE, Willett WC, De Vivo I. Lycopene and other
carotenoid intake in relation to risk of uterine leiomyomata. Am J Obstet
Gynecol. 2008 Jan;198(1):37.e1-8. Epub 2007 Nov 5. PubMed PMID: 17981250; PubMed
Central PMCID: PMC2390902.

83: Terry KL, De Vivo I, Hankinson SE, Spiegelman D, Wise LA, Missmer SA.
Anthropometric characteristics and risk of uterine leiomyoma. Epidemiology. 2007
Nov;18(6):758-63. PubMed PMID: 17917603.

84: McGrath M, Hankinson SE, De Vivo I. Cytochrome P450 1A1, cigarette smoking,
and risk of endometrial cancer (United States). Cancer Causes Control. 2007
Dec;18(10):1123-30. Epub 2007 Aug 24. PubMed PMID: 17717632.

85: Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. A
prospective study of dietary flavonoid intake and incidence of epithelial ovarian
cancer. Int J Cancer. 2007 Nov 15;121(10):2225-32. PubMed PMID: 17471564.

86: McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length,
cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol
Biomarkers Prev. 2007 Apr;16(4):815-9. PubMed PMID: 17416776.

87: Cox DG, Deer D, Guo Q, Tworoger SS, Hankinson SE, Hunter DJ, De Vivo I. The
p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses'
health studies. Cancer Causes Control. 2007 Aug;18(6):621-5. Epub 2007 Mar 27.
PubMed PMID: 17387621.

88: Genkinger JM, De Vivo I, Stampfer MJ, Giovannucci E, Michaud DS. Nonsteroidal
antiinflammatory drug use and risk of bladder cancer in the health professionals
follow-up study. Int J Cancer. 2007 May 15;120(10):2221-5. PubMed PMID: 17290403.

89: McGrath M, Michaud D, De Vivo I. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2
genes and bladder cancer risk in men and women. BMC Cancer. 2006 Oct 6;6:239.
PubMed PMID: 17026750; PubMed Central PMCID: PMC1613249.

90: Han J, Hankinson SE, De Vivo I. Polymorphisms in O6-methylguanine DNA
methyltransferase and endometrial cancer risk. Carcinogenesis. 2006
Nov;27(11):2281-5. Epub 2006 Jun 15. PubMed PMID: 16777993.

91: Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS. A
genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for
hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad
Sci U S A. 2006 May 2;103(18):6970-5. Epub 2006 Apr 25. PubMed PMID: 16641093;
PubMed Central PMCID: PMC1447594.

92: Huggins GS, Wong JY, Hankinson SE, De Vivo I. GATA5 activation of the
progesterone receptor gene promoter in breast cancer cells is influenced by the
+331G/A polymorphism. Cancer Res. 2006 Feb 1;66(3):1384-90. PubMed PMID:
16452193.

93: McGrath M, Michaud DS, De Vivo I. Hormonal and reproductive factors and the
risk of bladder cancer in women. Am J Epidemiol. 2006 Feb 1;163(3):236-44. Epub
2005 Nov 30. PubMed PMID: 16319290.

94: Holick CN, De Vivo I, Feskanich D, Giovannucci E, Stampfer M, Michaud DS.
Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and
risk of bladder cancer among women (United States). Cancer Causes Control. 2005
Dec;16(10):1135-45. PubMed PMID: 16215863.

95: Michaud DS, De Vivo I, Morris JS, Giovannucci E. Toenail selenium
concentrations and bladder cancer risk in women and men. Br J Cancer. 2005 Oct
3;93(7):804-6. PubMed PMID: 16175184; PubMed Central PMCID: PMC2361644.

96: McGrath M, Lee IM, Hankinson SE, Kraft P, Hunter DJ, Buring J, De Vivo I.
Androgen receptor polymorphisms and endometrial cancer risk. Int J Cancer. 2006
Mar 1;118(5):1261-8. PubMed PMID: 16161040.

97: Terry KL, De Vivo I, Titus-Ernstoff L, Shih MC, Cramer DW. Androgen receptor
cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer
risk. Cancer Res. 2005 Jul 1;65(13):5974-81. PubMed PMID: 15994977; PubMed
Central PMCID: PMC1364476.

98: Paynter RA, Hankinson SE, Colditz GA, Kraft P, Hunter DJ, De Vivo I. CYP19
(aromatase) haplotypes and endometrial cancer risk. Int J Cancer. 2005 Aug
20;116(2):267-74. Erratum in: Int J Cancer. 2008 Mar 15;122(6):1443. PubMed PMID:
15800924.

99: Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW. Genetic variation
in the progesterone receptor gene and ovarian cancer risk. Am J Epidemiol. 2005
Mar 1;161(5):442-51. PubMed PMID: 15718480; PubMed Central PMCID: PMC1380205.

100: Kang JH, Logroscino G, De Vivo I, Hunter D, Grodstein F. Apolipoprotein E,
cardiovascular disease and cognitive function in aging women. Neurobiol Aging.
2005 Apr;26(4):475-84. PubMed PMID: 15653176.

101: Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B,
Colditz GA, Hankinson SE. Smoking and the risk of endometrial cancer: results
from the Nurses' Health Study. Int J Cancer. 2005 May 10;114(6):996-1001. PubMed
PMID: 15645490.

102: Kraft P, Cox DG, Paynter RA, Hunter D, De Vivo I. Accounting for haplotype
uncertainty in matched association studies: a comparison of simple and flexible
techniques. Genet Epidemiol. 2005 Apr;28(3):261-72. PubMed PMID: 15637718.

103: Paynter RA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. No evidence of a
role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility.
Pharmacogenetics. 2004 Dec;14(12):851-6. PubMed PMID: 15608564.

104: De Vivo I, Hankinson SE, Colditz GA, Hunter DJ. The progesterone receptor
Val660-->Leu polymorphism and breast cancer risk. Breast Cancer Res.
2004;6(6):R636-9. Epub 2004 Sep 22. PubMed PMID: 15535845; PubMed Central PMCID:
PMC1064075.

105: McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De Vivo I.
Association between catechol-O-methyltransferase and phobic anxiety. Am J
Psychiatry. 2004 Sep;161(9):1703-5. PubMed PMID: 15337664.

106: Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. Estrogen
receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).
Cancer Causes Control. 2004 Aug;15(6):627-33. PubMed PMID: 15280642.

107: Paynter RA, Hankinson SE, Hunter DJ, De Vivo I. No association between MTHFR
677 C->T or 1298 A->C polymorphisms and endometrial cancer risk. Cancer Epidemiol
Biomarkers Prev. 2004 Jun;13(6):1088-9. PubMed PMID: 15184272.

108: Han J, Hankinson SE, Zhang SM, De Vivo I, Hunter DJ. Interaction between
genetic variations in DNA repair genes and plasma folate on breast cancer risk.
Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):520-4. PubMed PMID: 15066914.

109: Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. HSD17B1 gene
polymorphisms and risk of endometrial and breast cancer. Cancer Epidemiol
Biomarkers Prev. 2004 Feb;13(2):213-9. PubMed PMID: 14973105.

110: Han J, Hankinson SE, Hunter DJ, De Vivo I. Genetic variations in XRCC2 and
XRCC3 are not associated with endometrial cancer risk. Cancer Epidemiol
Biomarkers Prev. 2004 Feb;13(2):330-1. PubMed PMID: 14973095.

111: Duguay Y, McGrath M, Lépine J, Gagné JF, Hankinson SE, Colditz GA, Hunter
DJ, Plante M, Têtu B, Bélanger A, Guillemette C, De Vivo I. The functional UGT1A1
promoter polymorphism decreases endometrial cancer risk. Cancer Res. 2004 Feb
1;64(3):1202-7. PubMed PMID: 14871858.

112: Han J, Hankinson SE, De Vivo I, Spiegelman D, Tamimi RM, Mohrenweiser HW,
Colditz GA, Hunter DJ. A prospective study of XRCC1 haplotypes and their
interaction with plasma carotenoids on breast cancer risk. Cancer Res. 2003 Dec
1;63(23):8536-41. PubMed PMID: 14679022.

113: McGrath M, Hankinson SE, Arbeitman L, Colditz GA, Hunter DJ, De Vivo I.
Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and
endometrial cancer susceptibility. Carcinogenesis. 2004 Apr;25(4):559-65. Epub
2003 Dec 4. PubMed PMID: 14656940.

114: Cramer DW, Hornstein MD, McShane P, Powers RD, Lescault PJ, Vitonis AF, De
Vivo I. Human progesterone receptor polymorphisms and implantation failure during
in vitro fertilization. Am J Obstet Gynecol. 2003 Oct;189(4):1085-92. PubMed
PMID: 14586360.

115: Han J, Hankinson SE, Ranu H, De Vivo I, Hunter DJ. Polymorphisms in DNA
double-strand break repair genes and breast cancer risk in the Nurses' Health
Study. Carcinogenesis. 2004 Feb;25(2):189-95. Epub 2003 Oct 24. PubMed PMID:
14578164.

116: Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter
DJ. Interaction between a peroxisome proliferator-activated receptor gamma gene
polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003
Nov 15;12(22):2923-9. Epub 2003 Sep 23. PubMed PMID: 14506127.

117: Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC.
Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms.
Epidemiology. 2003 Sep;14(5):545-51. PubMed PMID: 14501269.

118: De Vivo I, Hankinson SE, Colditz GA, Hunter DJ. A functional polymorphism in
the progesterone receptor gene is associated with an increase in breast cancer
risk. Cancer Res. 2003 Sep 1;63(17):5236-8. PubMed PMID: 14500352.

119: Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC.
Association between self-reported environmental tobacco smoke exposure and lung
cancer: modification by GSTP1 polymorphism. Int J Cancer. 2003 May
10;104(6):758-63. PubMed PMID: 12640684.

120: Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ,
Byrne C. Polymorphisms in steroid hormone pathway genes and mammographic density.
Breast Cancer Res Treat. 2003 Jan;77(1):27-36. PubMed PMID: 12602902.

121: Han J, Hankinson SE, De Vivo I, Colditz GA, Hunter DJ. No association
between a stop codon polymorphism in RAD52 and breast cancer risk. Cancer
Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1138-9. PubMed PMID: 12376524.

122: De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA,
Hunter DJ. A functional polymorphism in the promoter of the progesterone receptor
gene associated with endometrial cancer risk. Proc Natl Acad Sci U S A. 2002 Sep
17;99(19):12263-8. Epub 2002 Sep 6. PubMed PMID: 12218173; PubMed Central PMCID:
PMC129433.

 

 


Immaculata De Vivo is an Associate Professor of Medicine and Epidemiology at the Harvard Medical School and Harvard School of Public Health. Dr. De Vivo oversees a laboratory that primarily focuses on the discovery and characterization of genetic biological markers that may modify disease susceptibility in human populations. Biological markers of interest include single nucleotide polymorphisms (SNPs), telomere length, and gene copy number variations (CNVs). Additionally, Dr. De Vivo is the director of the Dana Farber-Harvard Cancer Center High-Throughput Genotyping Core Facility.

Harvard School of Public Health

677 Huntington Ave.

Bldg 2 Rm 247

Boston, MA 02115

 

devivo@channing.harvard.edu

 

office: 617.525.2094

laboratory: 617.432.1642


Copyright 2014 Immaculata De Vivo Genomic Epidemiology Laboratory @ Harvard University. Terms of Service | Privacy Policy